Trial intelligence / Profile preview

Boceprevir in Previously Treated HIV/HCV Co-infection

NCT01335529Phase 2Completed

Sponsor
ANRS
Start
May 2011
Primary completion
May 2014
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of boceprevir in hepatitis C virus infection, sponsored by ANRS. Started May 2011; status: completed.

02

Drugs

boceprevir
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on NCT01335529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01335529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call